Categories: News

San Antonio Based Companies NanoHarmonics and Avagen Pharma Have Joined Forces to Transform Healthcare with Nanotechnology

SAN ANTONIO, Jan. 8, 2022 /PRNewswire-PRWeb/ — NanoHarmonics, a pioneer in nanotechnology diagnostics, has partnered with Avagen Pharma, a Texas based nano-pharmaceutical company to further its mission in transforming healthcare through disruptive nanotechnology.

Avagen Pharma focuses on novel pharmaceutical products using a patented nanotechnology called NanoPro Rx™. NanoHarmonics utilizes a proprietary form of nanotechnology, Quantum Dots, called Abacus™ in their patented diagnostic platform. “Our focus is to use nanotechnology to create or improve pharmaceutical and diagnostics within healthcare. This is a great time to bring together our different nanotechnology platforms and use internal synergies between both companies to improve the efficacy, safety, and accessibility of certain healthcare products for people all over the world,” says Justin Jones, CEO of Avagen Pharma.

“Our collaboration with Avagen Pharma will allow us to truly revolutionize healthcare through practical applications of nanotechnology,” says Jimi Sta Maria, Chairman and CEO of NanoHarmonics. Both companies will be jointly headquartered in San Antonio, TX.

More information about Avagen Pharma, Inc. can be found at http://www.AvagenPharma.com or follow Avagen Pharma on facebook, instagram and twitter.

About Avagen Pharma:

Avagen Pharma, Inc. is headquartered in San Antonio, TX. It focuses on products to fill voids where current options do not exist and creates faster and less invasive ways to improve current diagnostics. Avagen uses this expertise to focus on dynamic products that will truly enhance a person’s health and well-being.

About NanoHarmonics:

NanoHarmonics’ patented Quantum Dot technology, Abacus™ is the foundation of its diagnostic platform. NanoHarmonics helps create safer, more effective, and accessible products through quantitative diagnostics, biomarker detection, therapy monitoring and rapid resulting.

Media Contact

Erin Robinson, Avagen Pharma, 1 2144158773, erin@avagenpharma.com

Twitter

 

SOURCE Avagen Pharma

Staff

Recent Posts

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…

9 hours ago

Defence Announces Closing of Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…

14 hours ago

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

15 hours ago

purelyIV Launches Mobile App for Seamless Wellness Management

The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…

15 hours ago

Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…

15 hours ago